Kdo2-Lipid A ammonium

更新时间:2024-01-12 12:09:05

Kdo2-Lipid A ammonium结构式
Kdo2-Lipid A ammonium结构式
品牌特惠专场
常用名 Kdo2-Lipid A ammonium 英文名 Di[3-deoxy-D-Manno-octulosonyl]-lipid A (amMonium salt)
CAS号 1246298-62-3 分子量 2326.646
密度 N/A 沸点 N/A
分子式 C110H198N2Na4O39P2 熔点 N/A
MSDS N/A 闪点 N/A

 Kdo2-Lipid A ammonium用途


Kdo2脂质A铵是一种化学定义的脂多糖(LPS),其内毒素活性等同于LPS。Kdo2脂质A铵对TLR4具有高度选择性。Kdo2脂质A铵刺激TNF和PGE2的释放[1]。

 Kdo2-Lipid A ammonium名称

中文名 二[3-脱氧-D-甘露聚糖-八磺酰基]-脂质A(铵盐)
英文名 Tetrasodium 3-deoxy-6-[(1R)-1,2-dihydroxyethyl]hex-2-ulopyranonosyl-(2->4)-3-deoxy-6-[(1R)-1,2-dihydroxyethyl]hex-2-ulopyranonosyl-(2->6)-2-deoxy-2-{[(3R)-3-(dodecanoyloxy)tetradecanoyl]amino}-4-O-(hydroxyphosphinato)-3-O-[(3R)-3-(tetradecanoyloxy)tetradecanoyl]hexopyranosyl-(1->6)-2-deoxy-1-O-(hydroxyphosphinato)-3-O-[(3R)-3-hydroxytetradecanoyl]-2-{[(3R)-3-hydroxytetradecanoyl]amino}hexopyranose
英文别名 更多

 Kdo2-Lipid A ammonium生物活性

描述 Kdo2脂质A铵是一种化学定义的脂多糖(LPS),其内毒素活性等同于LPS。Kdo2脂质A铵对TLR4具有高度选择性。Kdo2脂质A铵刺激TNF和PGE2的释放[1]。
相关类别
靶点

TLR4

体外研究 Kdo2脂质A(1µM)刺激成年大鼠脊髓星形胶质细胞培养物中TNF和PGE2的释放[1]。RT-PCR[1]细胞系:TNF和PGE2浓度:1µM培养时间:结果:TNF和PGE2的蛋白质(mg)含量分别为6.2±0.6 ng/mL和1.4±0.3 ng/mL。
体内研究 KDO2脂质A(i.t.)激活大鼠的toll样受体4(TLR4)[1]。动物模型:大鼠(雄性Holzman-Sprague-Dawley,300-400克)[1]剂量:0.1至10微克给药:I.T。;0.1-10微克;结果:鞘内注射1µg Kdo2脂质A可引起痛觉超敏,注射Kdo2脂质A后动物出现疾病。
参考文献

[1]. Saito O, et al. Spinal glial TLR4-mediated nociception and production of prostaglandin E(2) and TNF. Br J Pharmacol. 2010;160(7):1754-1764.

 Kdo2-Lipid A ammonium物理化学性质

分子式 C110H198N2Na4O39P2
分子量 2326.646
精确质量 2325.263672
外观性状 固体
储存条件 20°C

 Kdo2-Lipid A ammonium英文别名

Tetrasodium 3-deoxy-6-[(1R)-1,2-dihydroxyethyl]hex-2-ulopyranonosyl-(2->4)-3-deoxy-6-[(1R)-1,2-dihydroxyethyl]hex-2-ulopyranonosyl-(2->6)-2-deoxy-2-{[(3R)-3-(dodecanoyloxy)tetradecanoyl]amino}-4-O-(hydroxyphosphinato)-3-O-[(3R)-3-(tetradecanoyloxy)tetradecanoyl]hexopyranosyl-(1->6)-2-deoxy-1-O-(hydroxyphosphinato)-3-O-[(3R)-3-hydroxytetradecanoyl]-2-{[(3R)-3-hydroxytetradecanoyl]amino}hexopyranose
Hexopyranose, O-3-deoxy-D-glycero-2-octulopyranonosyl-(2->4)-O-3-deoxy-D-glycero-2-octulopyranonosyl-(2->6)-O--2-deoxy-2-[[(3R)-1-oxo-3-[(1-oxododecyl)oxy]tetradecyl]amino]-3-O-[(3R)-1-oxo-3-[(1-oxotetradecyl)oxy]tetradecyl]-4-O-phosphonohexopyranosyl-(1->6)-2-deoxy-3-O-[(3R)-3-hydroxy-1-oxotetradecyl]-2-[[(3R)-3-hydroxy-1-oxotetradecyl]amino]-, 1-(dihydrogen phosphate), sodium salt (1:4)